December Trudhesa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trudhesa® Achieved nTRx of Over 58.4K in 2022; nTRx Increased by 19.4% in Q4 vs. Q3 2022 Net Product Revenue Finished Year at $12.7 Million; Increased 62% in Q4 vs. Q3 2022 to $5 Million Impel. | March 24, 2023

United statesMelyssa weibleAdrian adamsDecember trudhesaJanhavi mohiteDrug administrationAmerican headache societyExchange commissionImpel pharmaceuticals incAmerican academy of neurologyDevelopment rd expensesElixir health public relationsImpel pharmaceuticalsProduct revenue finished yearHost investor conference call todayChief executive officer